Brookdale Senior Living Inc (BKD)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Brookdale Senior Living Inc (BKD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012222
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Brookdale Senior Living Inc (Brookdale) operates senior living communities which provide properties with high quality service, care and living accommodations for residents. The company focuses on providing an independent living, assisted living, dementia care, skilled nursing, continuing care, retirement communities (CCRC) and living accommodations for residents. It also provides housing, hospitality services, ancillary services and health care services. The ancillary services programs, provides outpatient therapy, home health, personalized living and hospice services to residents and to seniors living outside communities. The company also offers management services to third parties. Brookdale is headquartered in Tennessee, the US.

Brookdale Senior Living Inc (BKD) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Brookdale Senior Living Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Brookdale Senior Living Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Brookdale Senior Living Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Brookdale Senior Living Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Brookdale Senior Living Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Brookdale Senior Living Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Brookdale Senior Living Completes Acquisition Of Seven Senior Living Communities From Chartwell Retirement Residences For US$81 Million 10
Brookdale Senior Living Acquires 12 Senior Living Communities For US$162 Million 12
Brookdale Senior Living Acquires Nine Senior Living Communities For US$121.3 Million 13
Emeritus Acquires The Inn At Spruce Wood For US$19.1 Million 14
Emeritus Acquires Village At Fillmore Pond For US$21 Million 15
Emeritus Acquires Remaining 81% Interest In Assisted Living Communities From Blackstone Real Estate 16
Brookdale Senior Completes Acquisition Of Two Senior Living Communities For US$19 Million 17
Equity Offering 18
Brookdale Senior Living Prices Public Offering of Shares for USD300 Million 18
Emeritus Files Registration Statement For Public Offering Of Securities 20
Debt Offering 21
Brookdale Exercises Over-Allotment Option For Public Offering Of Convertible Senior Notes Due 2018 For US$316.2 Million 21
Asset Transactions 23
Kandu Capital Acquires Two Senior Living Communities From Brookdale For US$7 Million 23
HCP Completes Acquisition Of Senior Housing Portfolio Of Emeritus And Blackstone For US$1.7 Billion 24
Cerulean Partners And Inland Real Estate Acquire Atrium of Belleville, Senior Living Facility 26
Acquisition 27
Brookdale Senior Living Completes Acquisition of Emeritus for USD2.8 Billion 27
Emeritus Corporation Completes Acquisition Of 91% Stake In Nurse on Call For US$102 Million 29
Brookdale Senior Living Inc – Key Competitors 30
Brookdale Senior Living Inc – Key Employees 31
Brookdale Senior Living Inc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 34
Financial Announcements 34
Aug 07, 2017: Brookdale Announces Second Quarter 2017 Results 34
Feb 13, 2017: Brookdale Announces Fourth Quarter and Full Year 2016 Results 37
Nov 01, 2016: Brookdale Announces Third Quarter 2016 Results 41
Aug 08, 2016: Brookdale Announces Second Quarter 2016 Results 45
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Brookdale Senior Living Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Brookdale Senior Living Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Brookdale Senior Living Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Brookdale Senior Living Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Brookdale Senior Living Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Brookdale Senior Living Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Brookdale Senior Living Completes Acquisition Of Seven Senior Living Communities From Chartwell Retirement Residences For US$81 Million 10
Brookdale Senior Living Acquires 12 Senior Living Communities For US$162 Million 12
Brookdale Senior Living Acquires Nine Senior Living Communities For US$121.3 Million 13
Emeritus Acquires The Inn At Spruce Wood For US$19.1 Million 14
Emeritus Acquires Village At Fillmore Pond For US$21 Million 15
Emeritus Acquires Remaining 81% Interest In Assisted Living Communities From Blackstone Real Estate 16
Brookdale Senior Completes Acquisition Of Two Senior Living Communities For US$19 Million 17
Brookdale Senior Living Prices Public Offering of Shares for USD300 Million 18
Emeritus Files Registration Statement For Public Offering Of Securities 20
Brookdale Exercises Over-Allotment Option For Public Offering Of Convertible Senior Notes Due 2018 For US$316.2 Million 21
Kandu Capital Acquires Two Senior Living Communities From Brookdale For US$7 Million 23
HCP Completes Acquisition Of Senior Housing Portfolio Of Emeritus And Blackstone For US$1.7 Billion 24
Cerulean Partners And Inland Real Estate Acquire Atrium of Belleville, Senior Living Facility 26
Brookdale Senior Living Completes Acquisition of Emeritus for USD2.8 Billion 27
Emeritus Corporation Completes Acquisition Of 91% Stake In Nurse on Call For US$102 Million 29
Brookdale Senior Living Inc, Key Competitors 30
Brookdale Senior Living Inc, Key Employees 31
Brookdale Senior Living Inc, Subsidiaries 32

★海外企業調査レポート[Brookdale Senior Living Inc (BKD)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AZTherapies Inc-製薬・医療分野:企業M&A・提携分析
    Summary AZTherapies Inc (AZTherapies) is a clinical-stage drug development company, which focuses on the discovery, development and commercialization of medicines for the treatment of Alzheimer’s disease and other neuroinflammatory and neurodegenerative diseases. Its product pipeline includes the le …
  • BerryPharma AG:企業の戦略・SWOT・財務情報
    BerryPharma AG - Strategy, SWOT and Corporate Finance Report Summary BerryPharma AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Lidco Group Plc (LID):企業の財務・戦略的SWOT分析
    Summary Lidco Group Plc (LiDCO) is a medical device company that supplies hemodynamic monitoring equipment. The company offers products such as LiDCOrapid, LiDCOunity, LiDCOplus, LiDCOview and LiDCOaccessories . Its LiDCOplus is a computer-based platform monitor, which is used in the intensive care …
  • Torque Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Torque Therapeutics Inc (Torque) is an immuno-oncology company focused on developing first-in-class deep primed T Cell therapeutics to cure cancer. Its product pipeline includes Deep IL-15 used for for hematologic and solid tumors; Deep IL-12 targeting solid tumors; and small-molecule Deep T …
  • Handok Inc (002390)-製薬・医療分野:企業M&A・提携分析
    Summary Handok Inc (Handok), formerly known as Handok Pharmaceuticals Co Ltd, is a pharmaceutical and health care company which develops, manufactures and distributes healthcare solutions. The company develops and provides pharmaceutical products including prescription drugs, OTC drugs, medical devi …
  • Teva Pharmaceutical Industries Limited:企業のM&A・事業提携・投資動向
    Teva Pharmaceutical Industries Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teva Pharmaceutical Industries Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • Teradyne Inc (TER):企業の財務・戦略的SWOT分析
    Teradyne Inc (TER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Viking Therapeutics Inc (VKTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Viking Therapeutics Inc (Viking Therapeutics) is a clinical-stage biopharmaceutical company that develops novel therapies for patients suffering from metabolic and endocrine disorders. The company’s lead clinical program product candidate include VK5211, an orally available, non-steroidal se …
  • Bloomberg L.P.:戦略・SWOT・企業財務分析
    Bloomberg L.P. - Strategy, SWOT and Corporate Finance Report Summary Bloomberg L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Population Genetics Technologies Ltd-医療機器分野:企業M&A・提携分析
    Summary Population Genetics Technologies Ltd (Population Genetics) is a biotechnology company that offers diagnostic test solutions. The company provides products such as diagnostic test kits, HIV diagnostic test systems, and HCV diagnostic test systems. Its diagnostic test kits provide reagent assa …
  • MPI Research Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MPI Research Inc (MPI) is a drug development contract research organization that offers contracted scientific research services. The organization’s services comprise drug safety services, discovery sciences solutions, bioanalytical and analytical solutions, surgical services and medical devi …
  • Discovery Communications, Inc.:企業の戦略・SWOT・財務情報
    Discovery Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Discovery Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • PolyPid Ltd-医療機器分野:企業M&A・提携分析
    Summary PolyPid Ltd (PolyPid) is a clinical stage pharmaceutical company that develops, manufactures and commercialize drugs for extended release and local delivery. The company develops its products using PLEX (Polymer-Lipid Encapsulation MatriX) platform, which helps in products. PolyPid’s pipelin …
  • ENERQOS SpA:電力:M&Aディール及び事業提携情報
    Summary Enerqos SpA (Enerqos), a subsidiary of Climate Change Capital Private Equity LP, is an energy service company that offer solutions to improve energy efficiency. The company operates in the planning, management, financing and monitoring of projects in the renewable energy sector. It implement …
  • Intuitive Surgical Inc (ISRG):企業の財務・戦略的SWOT分析
    Intuitive Surgical Inc (ISRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Banque Profil de Gestion SA:企業の戦略・SWOT・財務情報
    Banque Profil de Gestion SA - Strategy, SWOT and Corporate Finance Report Summary Banque Profil de Gestion SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Sinocare Meditech Inc:医療機器:M&Aディール及び事業提携情報
    Summary Sinocare Meditech Inc (Sinocare Meditech) formerly known as Freedom Meditech Inc, is a medical device company that provides ophthalmic medical devices. The company develops and commercializes ophthalmic medical devices for both chronic disease detection and the management of diabetes. It pro …
  • Aratana Therapeutics Inc (PETX):企業の財務・戦略的SWOT分析
    Summary Aratana Therapeutics Inc (Aratana) is a provider of pet care solutions. The company develops, commercializing and markets biopharmaceutical products for medical condition in cats and dogs. Its pipeline portfolio consists of small molecule pharmaceuticals and large molecule biologics that aim …
  • Natsionalna Elektricheska Kompania EAD:企業の戦略的SWOT分析
    Natsionalna Elektricheska Kompania EAD - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Aurora Spine Corp (ASG):企業の製品パイプライン分析2018
    Summary Aurora Spine Corp (Aurora) is a medical equipment provider that offers surgical tools. The company offers novel solutions in the spinal implant market through a range of minimally invasive, and regenerative spinal implant technologies. It develops and distributes spinal implant products whic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆